Stricker B H, Slagboom G, Demaeseneer R, Slootmaekers V, Thijs I, Olsson S
Netherlands Centre for Monitoring of Adverse Reactions to Drugs, Rijswijk.
BMJ. 1988 Dec 3;297(6661):1434-5. doi: 10.1136/bmj.297.6661.1434.
During 1981 to mid-1988 three cases of anaphylactic shock after treatment with the quinolone derivative cinoxacin were reviewed by the Netherlands Centre for Monitoring of Adverse Reactions to Drugs and 17 cases of an anaphylactic type of reaction notified to the World Health Organisation Collaborating Centre for International Drug Monitoring. In five out of six patients for whom data were available the reaction began shortly after taking a single capsule of a second or next course of treatment. Cinoxacin is related to nalidixic acid, and one patient previously treated with that agent subsequently had an anaphylactoid reaction to cinoxacin and later developed a skin reaction to nalidixic acid. There were no deaths, and patients treated as an emergency with plasma expanders or with adrenaline and corticosteroids generally recovered promptly and uneventfully. In view of the potentially fatal consequences of anaphylactic reactions to cinoxacin and other quinolones doctors should take care when prescribing these drugs.
1981年至1988年年中,荷兰药品不良反应监测中心回顾了3例使用喹诺酮衍生物西诺沙星治疗后发生过敏性休克的病例,以及向世界卫生组织国际药品监测合作中心报告的17例过敏样反应病例。在有数据可查的6名患者中,有5名在服用第二疗程或下一疗程的单粒胶囊后不久就出现了反应。西诺沙星与萘啶酸有关,1名先前接受过该药物治疗的患者随后对西诺沙星出现过敏样反应,后来对萘啶酸出现皮肤反应。没有死亡病例,使用血浆扩容剂或肾上腺素及皮质类固醇进行紧急治疗的患者通常迅速康复且无并发症。鉴于对西诺沙星和其他喹诺酮类药物过敏反应可能产生致命后果,医生在开这些药物时应谨慎。